Methylphenidate and stress exert influences on synaptic protein expression in a mouse model for attention-deficit/hyperactivity disorder

被引：0
|
作者：
Gruenblatt, E. [1 ]
Hall, S. F. [2 ]
Kreutzfeldt, M. [1 ]
Perona, M. T. [2 ]
Nietzer, S. [1 ]
Sora, I. [3 ]
Uhl, G. R. [2 ]
Riederer, R. [1 ]
Lesch, K. -P. [1 ]
Gerlach, M.
Schmitt, A. G. [1 ]
机构：
[1] Univ Wurzburg, Psychiat Clin, D-97070 Wurzburg, Germany
[2] NIDA, Mol Neurobiol Branch, Baltimore, MD USA
[3] Tohoku Univ, Dept Neurosci, Sendai, Miyagi 980, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [31] Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
    Rafał R. Jaeschke
    Ewelina Sujkowska
    Magdalena Sowa-Kućma
    Psychopharmacology, 2021, 238 : 2667 - 2691
  • [32] THE EFFECT OF METHYLPHENIDATE ON OCULAR MOVEMENTS IN THE ATTENTION-DEFICIT DISORDER WITH HYPERACTIVITY
    BLONDIS, TA
    SHAPIRO, BK
    CAPUTE, AJ
    ZEE, DS
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 1987, 8 (03): : 177 - 177
  • [33] Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
    Mandali, Alekhya
    Sethi, Arjun
    Cercignani, Mara
    Harrison, Neil A.
    Voon, Valerie
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [34] Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder
    Sugrue, David
    Bogner, Robin
    Ehret, Megan J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (14) : 1163 - 1170
  • [35] Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
    Alekhya Mandali
    Arjun Sethi
    Mara Cercignani
    Neil A. Harrison
    Valerie Voon
    Translational Psychiatry, 11
  • [36] An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/hyperactivity disorder
    Froelich, Jan
    Banaschewski, Tobias
    Doepfner, Manfred
    Goertz-Dorten, Anja
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (08) : 1169 - 1183
  • [37] Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate
    Wolraich, ML
    Doffing, MA
    CNS DRUGS, 2004, 18 (04) : 243 - 250
  • [38] Methylphenidate Treatment and Dyskinesia in Children with Attention-Deficit/Hyperactivity Disorder
    Balazs, Judit
    Dallos, Gyoengyver
    Kereszteny, Agnes
    Czobor, Pal
    Gadoros, Julia
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (02) : 133 - 138
  • [39] Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder
    Danielle C. Turner
    Andrew D. Blackwell
    Jonathan H. Dowson
    Andrew McLean
    Barbara J. Sahakian
    Psychopharmacology, 2005, 178 : 286 - 295
  • [40] An Adolescent with Kleptomania and Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate
    Herguner, Sabri
    Tanidir, Canan
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (04) : 383 - 384
12345